{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:58:05Z","timestamp":1761893885778,"version":"build-2065373602"},"reference-count":40,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T00:00:00Z","timestamp":1166054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:\u2002<\/jats:bold>\n                    Multidrug regimens in HIV disease are associated with an increased incidence of insulin resistance, by as much as 50%. Not only does insulin resistance predisposes subjects to diabetes but also it is associated with the metabolic syndrome and increased risk of cardiovascular disease. Previous studies suggest that chromium picolinate can improve insulin resistance in patients with type 2 diabetes. The objective was to study the efficacy and safety of chromium picolinate as a treatment of insulin resistance in subjects infected with HIV.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:\u2002<\/jats:bold>\n                    The ability of chromium picolinate (1000 \u03bcg\/day) to improve insulin sensitivity, determined with a hyperinsulinaemic\u2013euglycaemic insulin clamp, was determined in eight HIV\u2010positive subjects on highly active antiretroviral therapy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    The mean rate of glucose disposal during the clamp was 4.41 mg glucose\/kg lean body mass (LBM)\/min (range 2.67\u20135.50), which increased to 6.51 mg\/kg LBM\/min (range 3.19\u201312.78, p = .03), an increase of 25% after 8 weeks of treatment with chromium picolinate. There were no significant changes in blood parameters, HIV viral burden or CD4+ lymphocytes with chromium picolinate treatment. Two subjects experienced abnormalities of liver function during the study. Another subject experienced an elevation in blood urea nitrogen.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:\u2002<\/jats:bold>\n                    The study shows that chromium picolinate therapy improves insulin resistance in some HIV\u2010positive subjects, but with some concerns about safety in this population.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2006.00681.x","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T11:11:22Z","timestamp":1166094682000},"page":"151-158","source":"Crossref","is-referenced-by-count":7,"title":["Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study"],"prefix":"10.1111","volume":"10","author":[{"given":"J. J.","family":"Feiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"McNurlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Mynarcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Gelato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,12,14]]},"reference":[{"key":"e_1_2_7_2_2","article-title":"Reports of Diabetes and Hyperglycemia in Patients Receiving Protease Inhibitors for the Treatment of Human Immunodeficiency Virus (HIV)","author":"Lumpkin M","year":"1997","journal-title":"FDA Public Health Advisory"},{"doi-asserted-by":"publisher","key":"e_1_2_7_3_2","DOI":"10.1097\/00002030-199912240-00002"},{"doi-asserted-by":"publisher","key":"e_1_2_7_4_2","DOI":"10.2337\/diacare.28.11.2745"},{"doi-asserted-by":"publisher","key":"e_1_2_7_5_2","DOI":"10.1056\/NEJM199604113341504"},{"doi-asserted-by":"publisher","key":"e_1_2_7_6_2","DOI":"10.1016\/S0002-9343(97)00027-2"},{"key":"e_1_2_7_7_2","first-page":"C54","article-title":"Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes","volume":"22","author":"Haffner S","year":"1999","journal-title":"Diabetes Care"},{"doi-asserted-by":"publisher","key":"e_1_2_7_8_2","DOI":"10.1016\/S0149-2918(03)80283-7"},{"doi-asserted-by":"publisher","key":"e_1_2_7_9_2","DOI":"10.1056\/NEJMoa030218"},{"doi-asserted-by":"publisher","key":"e_1_2_7_10_2","DOI":"10.1097\/00002030-199907090-00001"},{"doi-asserted-by":"publisher","key":"e_1_2_7_11_2","DOI":"10.1016\/j.jhep.2006.01.024"},{"doi-asserted-by":"publisher","key":"e_1_2_7_12_2","DOI":"10.1097\/00007435-199407000-00008"},{"doi-asserted-by":"publisher","key":"e_1_2_7_13_2","DOI":"10.2337\/diab.46.11.1786"},{"doi-asserted-by":"publisher","key":"e_1_2_7_14_2","DOI":"10.1016\/0026-0495(83)90203-2"},{"key":"e_1_2_7_15_2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/ajcn\/54.5.909","article-title":"Supplemental chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low chromium diets","volume":"54","author":"Anderson R","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/ajcn\/24.11.1313","article-title":"Effect of chromium on glucose utilization in marasmic protein\u2010calorie malnutrition","volume":"24","author":"Gurson CT","year":"1971","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_7_17_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ajcn\/21.3.203","article-title":"Improvement of impaired carbohydrate metabolism by chromium 3 in malnourished infants","volume":"21","author":"Hopkins L","year":"1968","journal-title":"Am J Clin Nutr"},{"doi-asserted-by":"publisher","key":"e_1_2_7_18_2","DOI":"10.1016\/0026-0495(68)90137-6"},{"doi-asserted-by":"publisher","key":"e_1_2_7_19_2","DOI":"10.1016\/S0271-5317(85)80241-4"},{"doi-asserted-by":"publisher","key":"e_1_2_7_20_2","DOI":"10.1046\/j.1464-5491.2000.00342.x"},{"doi-asserted-by":"publisher","key":"e_1_2_7_21_2","DOI":"10.1016\/0026-0495(85)90001-0"},{"doi-asserted-by":"publisher","key":"e_1_2_7_22_2","DOI":"10.1016\/0026-0495(87)90100-4"},{"doi-asserted-by":"publisher","key":"e_1_2_7_23_2","DOI":"10.1016\/0168-8227(95)01097-W"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2337\/diab.29.11.919","article-title":"Beneficial effect of chromium\u2010rich yeast on glucose tolerance and blood lipids in elderly subjects","volume":"29","author":"Offenbacher EG","year":"1980","journal-title":"Diabetes"},{"doi-asserted-by":"publisher","key":"e_1_2_7_25_2","DOI":"10.1097\/00017285-199611000-00002"},{"doi-asserted-by":"publisher","key":"e_1_2_7_26_2","DOI":"10.7326\/0003-4819-126-5-199703010-00019"},{"doi-asserted-by":"publisher","key":"e_1_2_7_27_2","DOI":"10.1345\/aph.17327"},{"doi-asserted-by":"publisher","key":"e_1_2_7_28_2","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"doi-asserted-by":"publisher","key":"e_1_2_7_29_2","DOI":"10.1097\/00126334-200212150-00009"},{"doi-asserted-by":"publisher","key":"e_1_2_7_30_2","DOI":"10.1097\/00126334-200012010-00004"},{"doi-asserted-by":"publisher","key":"e_1_2_7_31_2","DOI":"10.1210\/jc.83.7.2461"},{"doi-asserted-by":"publisher","key":"e_1_2_7_32_2","DOI":"10.1016\/0026-0495(81)90074-3"},{"doi-asserted-by":"publisher","key":"e_1_2_7_33_2","DOI":"10.1001\/jama.284.4.472"},{"doi-asserted-by":"publisher","key":"e_1_2_7_34_2","DOI":"10.1073\/pnas.0636646100"},{"doi-asserted-by":"publisher","key":"e_1_2_7_35_2","DOI":"10.1096\/fasebj.9.15.8529845"},{"doi-asserted-by":"publisher","key":"e_1_2_7_36_2","DOI":"10.1016\/j.mrgentox.2005.09.001"},{"doi-asserted-by":"publisher","key":"e_1_2_7_37_2","DOI":"10.1016\/0048-9697(89)90200-3"},{"doi-asserted-by":"publisher","key":"e_1_2_7_38_2","DOI":"10.2337\/diacare.27.11.2741"},{"doi-asserted-by":"publisher","key":"e_1_2_7_39_2","DOI":"10.1080\/07315724.1998.10718802"},{"doi-asserted-by":"publisher","key":"e_1_2_7_40_2","DOI":"10.1016\/S0889-8529(05)70079-7"},{"key":"e_1_2_7_41_2","first-page":"41","article-title":"The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects","volume":"152","author":"Press RI","year":"1990","journal-title":"West J Med"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2006.00681.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2006.00681.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:11:58Z","timestamp":1761887518000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2006.00681.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,14]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1463-1326.2006.00681.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2006.00681.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"type":"print","value":"1462-8902"},{"type":"electronic","value":"1463-1326"}],"subject":[],"published":{"date-parts":[[2006,12,14]]}}}